| P2093 | author name string | Rahman Jamal | |
| | Ismail Sagap | |
| | Isa Mohamed Rose | |
| | Wan Zurinah Wan Ngah | |
| | Azmi Mohd Tamil | |
| | Roslan Harun | |
| | Norfilza M Mokhtar | |
| | Md Manir Hossain Mollah | |
| | Nurul Ainin Abdul Aziz | |
| P2860 | cites work | Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. | Q51597657 |
| | Descriptive statistics and graphical displays. | Q51938474 |
| | Bayesian robust inference for differential gene expression in microarrays with multiple samples. | Q51945684 |
| | Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer. | Q53289449 |
| | Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer | Q56601042 |
| | ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis | Q83167939 |
| | Summaries of Affymetrix GeneChip probe level data | Q27860888 |
| | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 |
| | Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value | Q28488319 |
| | Notch signaling in kidney development | Q28589148 |
| | Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy | Q28943514 |
| | Rectal cancer staging | Q30484651 |
| | Stromal gene expression predicts clinical outcome in breast cancer | Q33330931 |
| | Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets | Q33361596 |
| | Efficacy of postoperative concurrent chemoradiation for resectable rectal cancer: a single institute experience | Q33746878 |
| | Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging | Q33982101 |
| | Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer | Q34062558 |
| | Optimized application of penalized regression methods to diverse genomic data | Q34096074 |
| | Oncotype DX tumor gene expression profiling in stage II colon cancerApplication: Prognostic, risk prediction | Q34130871 |
| | β-empirical Bayes inference and model diagnosis of microarray data | Q34309083 |
| | Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing | Q34384230 |
| | Molecular staging for survival prediction of colorectal cancer patients | Q34420506 |
| | Liver development update: new embryo models, cell lineage control, and morphogenesis | Q35893556 |
| | Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology | Q36023435 |
| | Molecular biomarkers of colorectal cancer: prognostic and predictive tools for clinical practice | Q36219923 |
| | Epidermal growth factor receptor (EGFR) signaling in cancer | Q36353031 |
| | Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma | Q36494944 |
| | CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer | Q36544662 |
| | ELTD1, a potential new biomarker for gliomas | Q36564447 |
| | Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology. | Q37076532 |
| | Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled | Q37578725 |
| | Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis | Q37613290 |
| | Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. | Q40571922 |
| | Robust extraction of local structures by the minimum beta-divergence method | Q43846433 |
| | Robust QTL analysis by minimum β-divergence method | Q44668781 |
| | The three sorCS genes are differentially expressed and regulated by synaptic activity. | Q44792289 |
| | Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature | Q46252858 |
| | Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature | Q47606349 |
| | Identification of SorCS2, a novel member of the VPS10 domain containing receptor family, prominently expressed in the developing mouse brain. | Q49051456 |
| | ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. | Q50784314 |
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| | colorectal carcinoma | Q25493920 |
| P304 | page(s) | 58 | |
| P577 | publication date | 2016-09-08 | |
| P1433 | published in | BMC Medical Genomics | Q15754662 |
| P1476 | title | A 19-Gene expression signature as a predictor of survival in colorectal cancer | |
| P478 | volume | 9 | |